Drug Profile
J 956
Latest Information Update: 12 Feb 2008
Price :
$50
*
At a glance
- Originator EnTec
- Developer EnTec; TAP Pharmaceutical Products
- Class
- Mechanism of Action Selective progesterone receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Endometriosis; Menopausal syndrome; Uterine leiomyoma
Most Recent Events
- 13 Jun 2006 No development reported - Phase-II/III for Endometriosis in USA (unspecified route)
- 13 Jun 2006 No development reported - Phase-II/III for Menopausal syndrome in USA (unspecified route)
- 13 Jun 2006 No development reported - Phase-II/III for Uterine leiomyoma in USA (unspecified route)